About Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia
During the past decade, Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Acácio Alves Souza Lima-Filho" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "André Maia" with 1 trials as a collaborator and "Casa de Saúde São José" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia
According to Clinical.Site data, the most researched conditions in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" are
"Diabetic Macular Edema" (3 trials), "Endophthalmitis" (2 trials), "Macular Edema" (2 trials), "Ametropia" (1 trials) and "Aqueous Deficient Dry Eye Disease" (1 trials). Many other conditions were trialed in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" in a lesser frequency.
Clinical Trials Intervention Types at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia
Most popular intervention types in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" are "Drug" (11 trials), "Procedure" (6 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Ranibizumab" (2 trials) and "Acai dye 10%" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia
The vast majority of trials in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia" are
15 trials for "All" genders.
Clinical Trials Status at Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia
Currently, there are NaN active trials in "Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia".
undefined are not yet recruiting,
2 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universidade Federal de Sao Paulo - UNIFESP*X; Oftalmologia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 4 trials that are defined as “Not Applicable".